Reuters logo
BRIEF-Neurocrine Biosciences reports Q3 loss per share $0.13
November 1, 2017 / 11:38 PM / 22 days ago

BRIEF-Neurocrine Biosciences reports Q3 loss per share $0.13

Nov 1 (Reuters) - Neurocrine Biosciences Inc

* Neurocrine Biosciences reports third quarter 2017 results

* Q3 loss per share $0.13

* Q3 earnings per share view $-0.49 -- Thomson Reuters I/B/E/S

* Says net product sales of $45.8 million for three months ended September 30, 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below